- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04883060
Pilot Testing for Midline Measuring Device (MMD)
January 4, 2024 updated by: Matthew Howard, University of Iowa
Identifying the exact middling on the patient's head during the planning phase of surgery is crucial yet can be challenged by patient's head position and hair.
The investigators have invented a device that uses anatomical landmark to quickly and gracefully identify the midline on a patient's head.
The device is a U-shaped instrument equipped with a laser pointer at the midline.
The instrument also has smooth spheres that can be positioned over the patients' ears bilaterally.
The midline laser pointer will identify the midline on the patients' head.
this measurement procedure is typically done after the patient is placed under anesthesia.
The standard way of determining the midline on the skull is simply by surgeon's vision without any measurements.
This new technique will be contrasted against the standard way.
The device was invented by investigators in neurosurgery (led by Dr. Matthew Howard III).
This is not patented it at this time.
There is no company involved in manufacturing (assembly was completed with the help of the hospital's machine shop).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- Univeristy of Iowa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with normal pressure hydrocephalus who are scheduled to undergo a ventriculoperitoneal shunt surgery
Exclusion Criteria:
- Patients who are not able to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Patients undergoing ventriculoperitoneal surgery where the midline localizer was used
|
a midline localizer device with a laser pointer is used to localize where the midline is likely to be located on the patient head prior to the surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Midline Localization
Time Frame: Immediate postop, an average of 4 hours
|
The average distance separating the staple from the lateral edge of the sagittal sinus
|
Immediate postop, an average of 4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Burr Hole Placement
Time Frame: Immediately Post-op, an average of 4 hours
|
Number of participants in which their Burr hole placement was between 3 and 4 cm away from anatomical midline
|
Immediately Post-op, an average of 4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Actual)
July 1, 2019
Study Completion (Actual)
July 1, 2019
Study Registration Dates
First Submitted
May 6, 2021
First Submitted That Met QC Criteria
May 6, 2021
First Posted (Actual)
May 12, 2021
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 4, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 201704798
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventriculo-Peritoneal Shunt Infection
-
Mashhad University of Medical SciencesCompletedSubarachnoid Hemorrhage | Hydrocephalus | Ventriculo-Peritoneal Shunt InfectionIran, Islamic Republic of
-
University Hospital Inselspital, BerneCompletedKeyhole Surgery for the Positioning of the Distal Catheter in Ventricular Peritoneal Shunt PlacementRandomized Controlled Trial | Ventricular Peritoneal Shunt | Shunt Complications | Shunt FailureSwitzerland
-
University of PittsburghCompletedInfection | Ventriculoperitoneal ShuntUnited States
-
Assiut UniversityNot yet recruitingPostoperative Complications | Bacterial Infections and Mycoses | Prosthesis-Related Infections | Hydrocephalus | Hydrocephalus in Children | Hydrocephalus in Infants | Pediatric Hydrocephalus | Surgical Site Infection (SSI) | Ventriculoperitoneal Shunt Infection | Cerebrospinal Fluid Shunt InfectionEgypt
-
University of PittsburghCompletedVentricular Shunt InfectionUnited States
-
Baiyun LiuRecruitingHydrocephalus | Ventriculoperitoneal ShuntChina
-
University Hospital, CaenCompletedPeritoneal InfectionFrance
-
Carmel Medical CenterRecruitingPeritoneal Dialysis Catheter Infection | Peritoneal Dialysis-associated Peritonitis | Peritoneal Dialysis ComplicationIsrael
-
E-DA HospitalCompletedPeritoneal Dialysis Catheter Exit Site Infection
-
Hampshire Hospitals NHS Foundation TrustRecruitingPeritoneal Cancer | Infection;Post Surg ProcedureUnited Kingdom
Clinical Trials on midline localizer
-
University Hospital, GrenobleUniversity of BurgundyRecruitingCorticospinal Excitability | Cortical ActivationFrance
-
Hiroki YamaueKatsunari TakifujiUnknown
-
Hospital General Universitario de ValenciaCompletedVascular Access Complication | Vascular Access Device ComplicationsSpain
-
University Hospital OstravaCompleted
-
William Beaumont HospitalsWithdrawnDeep Vein Thrombosis | Vascular Access Complication | Central Line Complication | Superficial Vein Thrombosis | Central Line-Associated InfectionUnited States
-
Groupe Hospitalier Mutualiste de GrenobleTIMC-IMAG; Vygon GmbH & Co. KGCompletedIntravascular DeviceFrance
-
William Beaumont HospitalsTeleflexCompletedCatheter Infection | Catheter Complications | Catheter ThrombosisUnited States
-
Seoul National University HospitalRecruitingVascular Access Device ComplicationsSouth Korea
-
Sohag UniversityCompleted
-
Zagazig UniversityCompletedIncisional Hernia | Midline Incisions | High Risk Patients | Mesh Reinforcement